GLPMGRBydureon BCise injection sites: what the manufacturer says
This page lists where the manufacturer says Bydureon BCise (exenatide extended-release) can be injected in the UK and the EU, in their own words, with the documents each list comes from. It is not medical advice.
Talk to a healthcare professional. The injection areas shown come from the manufacturer's product information, and the heat map is your own record. GLPMGR is not a medical device and this is not medical advice: it can't tell you where it is safe for you to inject. Talk to your doctor, pharmacist or nurse about where and how to inject, follow the instructions from your prescriber and the leaflet supplied with your medicine, and ask a healthcare professional if you are unsure, or if you have pain, lumps, bruising or any other problem at an injection site.
Where Bydureon BCise can be injected
Manufacturer: AstraZeneca
United Kingdom
Areas listed:
- Abdomen
- Thigh
- Back of upper arm
Rotation, in the manufacturer’s words: “Subsequent injections should use a different site of injection each week.”
Source: MHRA products database / AstraZeneca UK Limited: Bydureon 2 mg prolonged-release suspension for injection in pre-filled pen (Bydureon BCise), Summary of Product Characteristics (PLGB 17901/0315, text revised 05/06/2024), revised 05/06/2024. Checked 20 September 2026.
Also consulted:
- MHRA products database / AstraZeneca UK Limited: Bydureon 2 mg powder and solvent for prolonged-release suspension in pre-filled pen, package leaflet (last revised July 2023) — The older Bydureon powder-and-solvent pen; the same three areas and rotation wording.
European Union
Areas listed:
- Stomach area (abdomen)
- Thigh
- Back of upper arm
Rotation, in the manufacturer’s words: “Subsequent injections should use a different site of injection each week.”
Source: EMA: Bydureon EPAR Product Information (English). Checked 20 September 2026.
United States
No longer marketed in this region, so GLPMGR holds no list for this medicine here and offers no sites for it.
Track your Bydureon BCise injection sites in GLPMGR
GLPMGR is a private GLP-1 tracker for iPhone, iPad and Apple Watch. Choose Bydureon BCise when you record a dose and it offers only the areas above for your region, shows a body map of where you have injected before, and shows the manufacturer’s rotation wording. It does not tell you where to inject, and it is independent of AstraZeneca.
Coming soon to the App Store
Other medicines with the same active ingredient:
Medical disclaimer
Talk to a healthcare professional. The injection areas shown come from the manufacturer's product information, and the heat map is your own record. GLPMGR is not a medical device and this is not medical advice: it can't tell you where it is safe for you to inject. Talk to your doctor, pharmacist or nurse about where and how to inject, follow the instructions from your prescriber and the leaflet supplied with your medicine, and ask a healthcare professional if you are unsure, or if you have pain, lumps, bruising or any other problem at an injection site.